191 related articles for article (PubMed ID: 32926612)
1. MALDI Mass Spectrometry Imaging in a Primary Demyelination Model of Murine Spinal Cord.
Sekera ER; Saraswat D; Zemaitis KJ; Sim FJ; Wood TD
J Am Soc Mass Spectrom; 2020 Dec; 31(12):2462-2468. PubMed ID: 32926612
[TBL] [Abstract][Full Text] [Related]
2. Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Keough MB; Jensen SK; Yong VW
J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867716
[TBL] [Abstract][Full Text] [Related]
3. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin.
Wang C; Kotter MR
Methods Mol Biol; 2018; 1791():233-241. PubMed ID: 30006714
[TBL] [Abstract][Full Text] [Related]
4. E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
Church JS; Milich LM; Lerch JK; Popovich PG; McTigue DM
Glia; 2017 Jun; 65(6):883-899. PubMed ID: 28251686
[TBL] [Abstract][Full Text] [Related]
5. Multiexponential T2 and magnetization transfer MRI of demyelination and remyelination in murine spinal cord.
McCreary CR; Bjarnason TA; Skihar V; Mitchell JR; Yong VW; Dunn JF
Neuroimage; 2009 May; 45(4):1173-82. PubMed ID: 19349232
[TBL] [Abstract][Full Text] [Related]
6. The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord.
Triarhou LC; Herndon RM
Arch Neurol; 1986 Feb; 43(2):121-5. PubMed ID: 3947247
[TBL] [Abstract][Full Text] [Related]
7. Remyelination in experimental models of toxin-induced demyelination.
Blakemore WF; Franklin RJ
Curr Top Microbiol Immunol; 2008; 318():193-212. PubMed ID: 18219819
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.
Plemel JR; Michaels NJ; Weishaupt N; Caprariello AV; Keough MB; Rogers JA; Yukseloglu A; Lim J; Patel VV; Rawji KS; Jensen SK; Teo W; Heyne B; Whitehead SN; Stys PK; Yong VW
Glia; 2018 Feb; 66(2):327-347. PubMed ID: 29068088
[TBL] [Abstract][Full Text] [Related]
9. Failure of remyelination in the nonhuman primate optic nerve.
Lachapelle F; Bachelin C; Moissonnier P; Nait-Oumesmar B; Hidalgo A; Fontaine D; Baron-Van Evercooren A
Brain Pathol; 2005 Jul; 15(3):198-207. PubMed ID: 16196386
[TBL] [Abstract][Full Text] [Related]
10. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats.
Gilson J; Blakemore WF
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):173-81. PubMed ID: 8316337
[TBL] [Abstract][Full Text] [Related]
11. Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye.
Baydyuk M; Cha DS; Hu J; Yamazaki R; Miller EM; Smith VN; Kelly KA; Huang JK
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14290-14299. PubMed ID: 31235582
[TBL] [Abstract][Full Text] [Related]
12. Application of q-Space Diffusion MRI for the Visualization of White Matter.
Fujiyoshi K; Hikishima K; Nakahara J; Tsuji O; Hata J; Konomi T; Nagai T; Shibata S; Kaneko S; Iwanami A; Momoshima S; Takahashi S; Jinzaki M; Suzuki N; Toyama Y; Nakamura M; Okano H
J Neurosci; 2016 Mar; 36(9):2796-808. PubMed ID: 26937016
[TBL] [Abstract][Full Text] [Related]
13. The expression of myelin protein mRNAs during remyelination of lysolecithin-induced demyelination.
Woodruff RH; Franklin RJ
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):226-35. PubMed ID: 10417664
[TBL] [Abstract][Full Text] [Related]
14. Defining Changes in the Spatial Distribution and Composition of Brain Lipids in the Shiverer and Cuprizone Mouse Models of Myelin Disease.
Maganti RJ; Hronowski XL; Dunstan RW; Wipke BT; Zhang X; Jandreski L; Hamann S; Juhasz P
J Histochem Cytochem; 2019 Mar; 67(3):203-219. PubMed ID: 30501365
[TBL] [Abstract][Full Text] [Related]
15. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination.
Pavelko KD; van Engelen BG; Rodriguez M
J Neurosci; 1998 Apr; 18(7):2498-505. PubMed ID: 9502810
[TBL] [Abstract][Full Text] [Related]
16. Characterizing Structural Changes With Devolving Remyelination Following Experimental Demyelination Using High Angular Resolution Diffusion MRI and Texture Analysis.
Luo T; Oladosu O; Rawji KS; Zhai P; Pridham G; Hossain S; Zhang Y
J Magn Reson Imaging; 2019 Jun; 49(6):1750-1759. PubMed ID: 30230112
[TBL] [Abstract][Full Text] [Related]
17. Observations on remyelination in the rabbit spinal cord following demyelination induced by lysolecithin.
Blakemore WF
Neuropathol Appl Neurobiol; 1978; 4(1):47-59. PubMed ID: 683458
[TBL] [Abstract][Full Text] [Related]
18. Remyelination induced by a DNA aptamer in a mouse model of multiple sclerosis.
Nastasijevic B; Wright BR; Smestad J; Warrington AE; Rodriguez M; Maher LJ
PLoS One; 2012; 7(6):e39595. PubMed ID: 22761835
[TBL] [Abstract][Full Text] [Related]
19. Neuregulin-1 promotes remyelination and fosters a pro-regenerative inflammatory response in focal demyelinating lesions of the spinal cord.
Kataria H; Alizadeh A; Shahriary GM; Saboktakin Rizi S; Henrie R; Santhosh KT; Thliveris JA; Karimi-Abdolrezaee S
Glia; 2018 Mar; 66(3):538-561. PubMed ID: 29148104
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
